1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 96. Andrews M G, Miller J L, Allen C, Hagemann T M, Harrison D, Johnson P N. Implementation of a bowel regimen regimen protocol in critically ill children: A pilot study. Journal of Pediatric Intensive Care. 2013; 2 : 63-69
97. Andrews M A, Patel R, Miller J L. Treatment of invasive Candida infections in the neonatal intensive care unit. Current Fungal Infection Reports. 2013; 7 : 96-109
98. Condren M, Miller J L. Pediatric dermatology. American College of Clinical Pharmacy. 2013
99. Johnson P N, Miller J L, Hagemann T M. Sedation and analgesia in critically ill children. AACN advanced critical care. 2012; 23 : 415-34; quiz 435-6
100. Johnson P N, Harrison D, Castro C H, Miller J L. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home. Research in social & administrative pharmacy : RSAP. 2012; 8 : 455-63
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.
5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.